Brock TA[au] - Search Results

Year	Number of Results
1979	1
1981	1
1982	4
1983	1
1984	2
1985	6
1986	4
1987	4
1988	5
1989	3
1990	4
1991	3
1993	2
1994	2
1995	3
1996	1
1997	5
1998	1
1999	6
2000	2
2001	5
2002	1
2003	2
2004	1
2008	1
2018	1
2022	1

1

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension.

Tilton RG, Brock TA, Dixon RA. Tilton RG, et al. Among authors: brock ta. Expert Opin Investig Drugs. 2001 Jul;10(7):1291-308. doi: 10.1517/13543784.10.7.1291. Expert Opin Investig Drugs. 2001. PMID: 11772252 Review.

2

Vascular endothelial growth factor, a multifunctional polypeptide.

Stephan CC, Brock TA. Stephan CC, et al. Among authors: brock ta. P R Health Sci J. 1996 Sep;15(3):169-78. P R Health Sci J. 1996. PMID: 8994281 Review.

3

50 Years of the Radiation Exposure Information and Reporting System.

Hagemeyer D, Nichols G, Mumma MT, Boice JD, Brock TA. Hagemeyer D, et al. Among authors: brock ta. Int J Radiat Biol. 2022;98(4):568-571. doi: 10.1080/09553002.2018.1540896. Epub 2018 Nov 19. Int J Radiat Biol. 2022. PMID: 30359149

4

Superoxide and peroxynitrite in atherosclerosis.

White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, et al. White CR, et al. Among authors: brock ta. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1044-8. doi: 10.1073/pnas.91.3.1044. Proc Natl Acad Sci U S A. 1994. PMID: 8302829 Free PMC article.

5

Recently discovered sulfonamide-, acyl sulfonamide- and carboxylic acid-based endothelin antagonists.

Wu C, Holland GW, Brock TA, Dixon RA. Wu C, et al. Among authors: brock ta. IDrugs. 2003 Mar;6(3):232-9. IDrugs. 2003. PMID: 12789612 Review.

6

Nonpeptide endothelin antagonists in clinical development.

Wu C, Decker ER, Holland GW, Brown PM, Stavros FD, Brock TA, Dixon RA. Wu C, et al. Among authors: brock ta. Drugs Today (Barc). 2001 Jul;37(7):441-453. doi: 10.1358/dot.2001.37.7.844187. Drugs Today (Barc). 2001. PMID: 12750762

7

Thrombin-stimulated events in cultured vascular smooth-muscle cells.

Berk BC, Taubman MB, Griendling KK, Cragoe EJ Jr, Fenton JW, Brock TA. Berk BC, et al. Among authors: brock ta. Biochem J. 1991 Mar 15;274 ( Pt 3)(Pt 3):799-805. doi: 10.1042/bj2740799. Biochem J. 1991. PMID: 2012607 Free PMC article.

8

JAM2 interacts with alpha4beta1. Facilitation by JAM3.

Cunningham SA, Rodriguez JM, Arrate MP, Tran TM, Brock TA. Cunningham SA, et al. Among authors: brock ta. J Biol Chem. 2002 Aug 2;277(31):27589-92. doi: 10.1074/jbc.C200331200. Epub 2002 Jun 17. J Biol Chem. 2002. PMID: 12070135 Free article.

9

The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia.

Mnjoyan ZH, Doan D, Brandon JL, Felix K, Sitter CL, Rege AA, Brock TA, Fujise K. Mnjoyan ZH, et al. Among authors: brock ta. Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2276-84. doi: 10.1152/ajpheart.91527.2007. Epub 2008 Mar 7. Am J Physiol Heart Circ Physiol. 2008. PMID: 18326792 Free article.

10

Development of intramolecularly quenched fluorescent peptides as substrates of angiotensin-converting enzyme 2.

Yan ZH, Ren KJ, Wang Y, Chen S, Brock TA, Rege AA. Yan ZH, et al. Among authors: brock ta. Anal Biochem. 2003 Jan 15;312(2):141-7. doi: 10.1016/s0003-2697(02)00461-x. Anal Biochem. 2003. PMID: 12531198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results